-+ 0.00%
-+ 0.00%
-+ 0.00%

Kymera Therapeutics Chief Business Officer Noah Goodman sells 1,347 shares for $121,230

PUBT·04/16/2026 22:30:42
Listen to the news
Kymera Therapeutics Chief Business Officer Noah Goodman sells 1,347 shares for $121,230
  • Kymera Therapeutics Chief Business Officer Noah Goodman sold 1,347 shares on April 14, 2026 at USD 90 per share.
  • Goodman held 50,195 shares following transaction.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kymera Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-159539), on April 16, 2026, and is solely responsible for the information contained therein.